Tag: Immune Disorders
Study IDs Risks to Offspring Associated With Prenatal Opioid Exposure
Prenatal opioid exposure linked to increased risk for infection, eczema and dermatitis, and asthma in offspring
Bidirectional Link ID’d for Autoimmune Disease, Perinatal Depression
Bidirectional association more pronounced among women without psychiatric comorbidities, strongest for multiple sclerosis
Disease-Modifying Antirheumatic Drugs May Cut Incidence of Autoimmune Thyroid Disease
Findings seen among adults after diagnosis with rheumatoid arthritis
Fourth COVID-19 Shot Beneficial in Patients With Autoimmune Rheumatic Diseases
Fourth dose reduces risk for SARS-CoV-2 for patients with systemic autoimmune rheumatic diseases using DMARDs
ACR: Incidence of Atrioventricular Block Increased With High Levels of Anti-SSA/Ro Antibodies
Incidence of atrioventricular block increased with higher antibody levels, reaching 7.7 percent in top quartile of anti-60 kD SSA-Ro
COVID-19 podría aumentar el riesgo de trastornos inmunológicos como alopecia y enfermedad de Crohn,...
Un nuevo estudio sugiere que las personas con antecedentes de COVID-19 podrían enfrentar mayores probabilidades de padecer trastornos autoinmunes y autoinflamatorios, incluida la alopecia, la enfermedad de Crohn y la vasculitis.
COVID-19 May Raise Risk for Immune Disorders like Alopecia and Crohn’s, New Study Finds
A new study suggests people with a history of COVID-19 may face increased odds for autoimmune and autoinflammatory disorders, including alopecia, Crohn’s disease and vasculitis.
Autoimmune, Autoinflammatory Connective Tissue Disorders Increased After COVID-19
Risks associated with COVID-19 severity
Efgartigimod Efficacious, Safe for Primary Immune Thrombocytopenia
More patients receiving efgartigimod reached primary end point of sustained platelet count response
Some Immunosuppressed Do Not Have Anti-Spike Antibodies After COVID-19 Vaccination
IgG anti-spike antibodies undetectable in ~20 percent with immunosuppression who had received three or more COVID-19 vaccines